Pregnancy-specific Vitamin C is required to make collagen, a component of skin, blood vessels, tendons, and the organic matrix of bone
GLP-1 medications work on appetite and blood sugar regulation but do not directly compromise blood cell counts, clotting factors, or immune function in ways that would contaminate the blood supply
Key Takeaways BPC-157 reduces inflammatory cytokines by 40-60% within two weeks at therapeutic doses TB-500 provides systemic anti-inflammatory effects through enhanced cellular repair mechanisms Thymosin alpha-1 specifically targets immune-mediated inflammation in autoimmune conditions Clinical protocols typically show results within 7-14 days with minimal reported side effects Medical supervision ensures proper dosing and monitoring for optimal therapeutic outcomes BPC-157: The Gut-Brain Anti-Inflammatory Peptide BPC-157 demonstrates the most consistent anti-inflammatory effects among therapeutic peptides, with studies showing 50-70% reduction in pro-inflammatory markers including TNF-alpha and interleukin-6
Taken together, it would be beneficial in patients with diabetes mellitus to choose antidiabetic agents that might be able to decrease the risk of thromboembolic events
Researchers are also beginning to explore next-generation approaches, including therapies that combine GLP-1s with estrogen